UR CTSI Career Development Scholar Links Frailty to Inflammation in Cancer Patients

Women with breast cancer are more likely to be frail after chemotherapy if they have greater increases of inflammation in their blood during chemotherapy, according to a study published by a UR CTSI KL2 Career Development scholar.

UR CTSI-Funded Researcher Finds Negative Effects of Caffeine in Utero

Research led in part by a UR CTSI-funded researcher suggests drinking caffeine while pregnant can lead to structural brain changes and behavioral issues in children later in life. 

Blood Cancer Research Moves from Lab to Clinic with UR CTSI Help

With the help of a UR CTSI Incubator Award, Wilmot Cancer Institute researcher Laura Calvi, M.D, has translated discoveries from the lab to a clinical trial that has begun to help patients with blood cancer. 

Improving Clinical Research by Empowering Participants

Participant feedback can help organizations improve their clinical trials, but many organizations lack the infrastructure to collect this feedback. The UR CTSI is part of a collaborative project to build such an infrastructure.

Case Study: A Single Drug for Multiple Allergies

It can be difficult to treat people with multiple allergic conditions, because drugs are usually tested against a single disease at a time. A recent case study highlights how the drug dupilumab drastically improved symptoms of multiple allergic diseases and quality of life for a young boy.